-+ 0.00%
-+ 0.00%
-+ 0.00%

Canaccord Genuity Maintains Buy on Enovis, Lowers Price Target to $58

Benzinga·08/08/2025 21:10:52
Listen to the news
Canaccord Genuity analyst Caitlin Cronin maintains Enovis (NYSE:ENOV) with a Buy and lowers the price target from $70 to $58.